Additional data from BROADWAY, BROOKLYN, and TANDEM to be presented throughout 2025; expected to support global regulatory filings for obicetrapib, including EMA submission in 2H25 by our partner ...
Smart money moves for your small business Grow your small business with tailored insights and recommendations. Grow your small business with tailored recommendations. $15 monthly fee. Monthly ...